Anthrax Vaccines Market - Global Outlook and Forecast 2022-2028

Anthrax Vaccines Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Anthrax Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anthrax Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anthrax Vaccines Overall Market Size
2.1 Global Anthrax Vaccines Market Size: 2021 VS 2028
2.2 Global Anthrax Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anthrax Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Anthrax Vaccines Players in Global Market
3.2 Top Global Anthrax Vaccines Companies Ranked by Revenue
3.3 Global Anthrax Vaccines Revenue by Companies
3.4 Global Anthrax Vaccines Sales by Companies
3.5 Global Anthrax Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anthrax Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anthrax Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anthrax Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Anthrax Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Anthrax Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anthrax Vaccines Market Size Markets, 2021 & 2028
4.1.2 Live Vaccines
4.1.3 Cell free PA Vaccines
4.2 By Type - Global Anthrax Vaccines Revenue & Forecasts
4.2.1 By Type - Global Anthrax Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Anthrax Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Anthrax Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Anthrax Vaccines Sales & Forecasts
4.3.1 By Type - Global Anthrax Vaccines Sales, 2017-2022
4.3.2 By Type - Global Anthrax Vaccines Sales, 2023-2028
4.3.3 By Type - Global Anthrax Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anthrax Vaccines Market Size, 2021 & 2028
5.1.2 Human Use
5.1.3 Animal Use
5.2 By Application - Global Anthrax Vaccines Revenue & Forecasts
5.2.1 By Application - Global Anthrax Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Anthrax Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Anthrax Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Anthrax Vaccines Sales & Forecasts
5.3.1 By Application - Global Anthrax Vaccines Sales, 2017-2022
5.3.2 By Application - Global Anthrax Vaccines Sales, 2023-2028
5.3.3 By Application - Global Anthrax Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Anthrax Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Anthrax Vaccines Revenue & Forecasts
6.2.1 By Region - Global Anthrax Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Anthrax Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Anthrax Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Anthrax Vaccines Sales & Forecasts
6.3.1 By Region - Global Anthrax Vaccines Sales, 2017-2022
6.3.2 By Region - Global Anthrax Vaccines Sales, 2023-2028
6.3.3 By Region - Global Anthrax Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Anthrax Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Anthrax Vaccines Sales, 2017-2028
6.4.3 US Anthrax Vaccines Market Size, 2017-2028
6.4.4 Canada Anthrax Vaccines Market Size, 2017-2028
6.4.5 Mexico Anthrax Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Anthrax Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Anthrax Vaccines Sales, 2017-2028
6.5.3 Germany Anthrax Vaccines Market Size, 2017-2028
6.5.4 France Anthrax Vaccines Market Size, 2017-2028
6.5.5 U.K. Anthrax Vaccines Market Size, 2017-2028
6.5.6 Italy Anthrax Vaccines Market Size, 2017-2028
6.5.7 Russia Anthrax Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Anthrax Vaccines Market Size, 2017-2028
6.5.9 Benelux Anthrax Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Anthrax Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Anthrax Vaccines Sales, 2017-2028
6.6.3 China Anthrax Vaccines Market Size, 2017-2028
6.6.4 Japan Anthrax Vaccines Market Size, 2017-2028
6.6.5 South Korea Anthrax Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Anthrax Vaccines Market Size, 2017-2028
6.6.7 India Anthrax Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Anthrax Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Anthrax Vaccines Sales, 2017-2028
6.7.3 Brazil Anthrax Vaccines Market Size, 2017-2028
6.7.4 Argentina Anthrax Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anthrax Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Anthrax Vaccines Sales, 2017-2028
6.8.3 Turkey Anthrax Vaccines Market Size, 2017-2028
6.8.4 Israel Anthrax Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Anthrax Vaccines Market Size, 2017-2028
6.8.6 UAE Anthrax Vaccines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Emergent BioSolutions
7.1.1 Emergent BioSolutions Corporate Summary
7.1.2 Emergent BioSolutions Business Overview
7.1.3 Emergent BioSolutions Anthrax Vaccines Major Product Offerings
7.1.4 Emergent BioSolutions Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Emergent BioSolutions Key News
7.2 Merial
7.2.1 Merial Corporate Summary
7.2.2 Merial Business Overview
7.2.3 Merial Anthrax Vaccines Major Product Offerings
7.2.4 Merial Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Merial Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Anthrax Vaccines Major Product Offerings
7.3.4 Merck Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Zoetis
7.4.1 Zoetis Corporate Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Anthrax Vaccines Major Product Offerings
7.4.4 Zoetis Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Zoetis Key News
7.5 Bayer Sanidad Animal
7.5.1 Bayer Sanidad Animal Corporate Summary
7.5.2 Bayer Sanidad Animal Business Overview
7.5.3 Bayer Sanidad Animal Anthrax Vaccines Major Product Offerings
7.5.4 Bayer Sanidad Animal Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Sanidad Animal Key News
7.6 Colorado Serum
7.6.1 Colorado Serum Corporate Summary
7.6.2 Colorado Serum Business Overview
7.6.3 Colorado Serum Anthrax Vaccines Major Product Offerings
7.6.4 Colorado Serum Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Colorado Serum Key News
7.7 PharmAthene
7.7.1 PharmAthene Corporate Summary
7.7.2 PharmAthene Business Overview
7.7.3 PharmAthene Anthrax Vaccines Major Product Offerings
7.7.4 PharmAthene Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 PharmAthene Key News
7.8 Tiankang
7.8.1 Tiankang Corporate Summary
7.8.2 Tiankang Business Overview
7.8.3 Tiankang Anthrax Vaccines Major Product Offerings
7.8.4 Tiankang Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Tiankang Key News
7.9 Biogénesis-Bago
7.9.1 Biogénesis-Bago Corporate Summary
7.9.2 Biogénesis-Bago Business Overview
7.9.3 Biogénesis-Bago Anthrax Vaccines Major Product Offerings
7.9.4 Biogénesis-Bago Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Biogénesis-Bago Key News
7.10 CAVAC
7.10.1 CAVAC Corporate Summary
7.10.2 CAVAC Business Overview
7.10.3 CAVAC Anthrax Vaccines Major Product Offerings
7.10.4 CAVAC Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 CAVAC Key News
7.11 Rosenbusch
7.11.1 Rosenbusch Corporate Summary
7.11.2 Rosenbusch Anthrax Vaccines Business Overview
7.11.3 Rosenbusch Anthrax Vaccines Major Product Offerings
7.11.4 Rosenbusch Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Rosenbusch Key News
7.12 Agrovet
7.12.1 Agrovet Corporate Summary
7.12.2 Agrovet Anthrax Vaccines Business Overview
7.12.3 Agrovet Anthrax Vaccines Major Product Offerings
7.12.4 Agrovet Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 Agrovet Key News
7.13 Vecol
7.13.1 Vecol Corporate Summary
7.13.2 Vecol Anthrax Vaccines Business Overview
7.13.3 Vecol Anthrax Vaccines Major Product Offerings
7.13.4 Vecol Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 Vecol Key News
7.14 CVCRI
7.14.1 CVCRI Corporate Summary
7.14.2 CVCRI Business Overview
7.14.3 CVCRI Anthrax Vaccines Major Product Offerings
7.14.4 CVCRI Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 CVCRI Key News
7.15 IVPM
7.15.1 IVPM Corporate Summary
7.15.2 IVPM Business Overview
7.15.3 IVPM Anthrax Vaccines Major Product Offerings
7.15.4 IVPM Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 IVPM Key News
7.16 Prondil
7.16.1 Prondil Corporate Summary
7.16.2 Prondil Business Overview
7.16.3 Prondil Anthrax Vaccines Major Product Offerings
7.16.4 Prondil Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Prondil Key News
7.17 CDV
7.17.1 CDV Corporate Summary
7.17.2 CDV Business Overview
7.17.3 CDV Anthrax Vaccines Major Product Offerings
7.17.4 CDV Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 CDV Key News
7.18 Indian Immunologicals
7.18.1 Indian Immunologicals Corporate Summary
7.18.2 Indian Immunologicals Business Overview
7.18.3 Indian Immunologicals Anthrax Vaccines Major Product Offerings
7.18.4 Indian Immunologicals Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.18.5 Indian Immunologicals Key News
7.19 Botswana Vaccine Institute
7.19.1 Botswana Vaccine Institute Corporate Summary
7.19.2 Botswana Vaccine Institute Business Overview
7.19.3 Botswana Vaccine Institute Anthrax Vaccines Major Product Offerings
7.19.4 Botswana Vaccine Institute Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.19.5 Botswana Vaccine Institute Key News
7.20 Ceva Santé Animale
7.20.1 Ceva Santé Animale Corporate Summary
7.20.2 Ceva Santé Animale Business Overview
7.20.3 Ceva Santé Animale Anthrax Vaccines Major Product Offerings
7.20.4 Ceva Santé Animale Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.20.5 Ceva Santé Animale Key News
7.21 Intervac
7.21.1 Intervac Corporate Summary
7.21.2 Intervac Business Overview
7.21.3 Intervac Anthrax Vaccines Major Product Offerings
7.21.4 Intervac Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.21.5 Intervac Key News
7.22 JOVAC
7.22.1 JOVAC Corporate Summary
7.22.2 JOVAC Business Overview
7.22.3 JOVAC Anthrax Vaccines Major Product Offerings
7.22.4 JOVAC Anthrax Vaccines Sales and Revenue in Global (2017-2022)
7.22.5 JOVAC Key News
8 Global Anthrax Vaccines Production Capacity, Analysis
8.1 Global Anthrax Vaccines Production Capacity, 2017-2028
8.2 Anthrax Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Anthrax Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anthrax Vaccines Supply Chain Analysis
10.1 Anthrax Vaccines Industry Value Chain
10.2 Anthrax Vaccines Upstream Market
10.3 Anthrax Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anthrax Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anthrax Vaccines in Global Market
Table 2. Top Anthrax Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anthrax Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anthrax Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Anthrax Vaccines Sales by Companies, (M Doses), 2017-2022
Table 6. Global Anthrax Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anthrax Vaccines Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Anthrax Vaccines Product Type
Table 9. List of Global Tier 1 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Anthrax Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anthrax Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anthrax Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anthrax Vaccines Sales (M Doses), 2017-2022
Table 15. By Type - Global Anthrax Vaccines Sales (M Doses), 2023-2028
Table 16. By Application - Global Anthrax Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anthrax Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anthrax Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anthrax Vaccines Sales (M Doses), 2017-2022
Table 20. By Application - Global Anthrax Vaccines Sales (M Doses), 2023-2028
Table 21. By Region - Global Anthrax Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anthrax Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anthrax Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anthrax Vaccines Sales (M Doses), 2017-2022
Table 25. By Region - Global Anthrax Vaccines Sales (M Doses), 2023-2028
Table 26. By Country - North America Anthrax Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anthrax Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anthrax Vaccines Sales, (M Doses), 2017-2022
Table 29. By Country - North America Anthrax Vaccines Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Anthrax Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anthrax Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anthrax Vaccines Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Anthrax Vaccines Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Anthrax Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anthrax Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anthrax Vaccines Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Anthrax Vaccines Sales, (M Doses), 2023-2028
Table 38. By Country - South America Anthrax Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anthrax Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anthrax Vaccines Sales, (M Doses), 2017-2022
Table 41. By Country - South America Anthrax Vaccines Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Anthrax Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anthrax Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anthrax Vaccines Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Anthrax Vaccines Sales, (M Doses), 2023-2028
Table 46. Emergent BioSolutions Corporate Summary
Table 47. Emergent BioSolutions Anthrax Vaccines Product Offerings
Table 48. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Merial Corporate Summary
Table 50. Merial Anthrax Vaccines Product Offerings
Table 51. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Anthrax Vaccines Product Offerings
Table 54. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Zoetis Corporate Summary
Table 56. Zoetis Anthrax Vaccines Product Offerings
Table 57. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Bayer Sanidad Animal Corporate Summary
Table 59. Bayer Sanidad Animal Anthrax Vaccines Product Offerings
Table 60. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Colorado Serum Corporate Summary
Table 62. Colorado Serum Anthrax Vaccines Product Offerings
Table 63. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. PharmAthene Corporate Summary
Table 65. PharmAthene Anthrax Vaccines Product Offerings
Table 66. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Tiankang Corporate Summary
Table 68. Tiankang Anthrax Vaccines Product Offerings
Table 69. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Biogénesis-Bago Corporate Summary
Table 71. Biogénesis-Bago Anthrax Vaccines Product Offerings
Table 72. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. CAVAC Corporate Summary
Table 74. CAVAC Anthrax Vaccines Product Offerings
Table 75. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. Rosenbusch Corporate Summary
Table 77. Rosenbusch Anthrax Vaccines Product Offerings
Table 78. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Agrovet Corporate Summary
Table 80. Agrovet Anthrax Vaccines Product Offerings
Table 81. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 82. Vecol Corporate Summary
Table 83. Vecol Anthrax Vaccines Product Offerings
Table 84. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 85. CVCRI Corporate Summary
Table 86. CVCRI Anthrax Vaccines Product Offerings
Table 87. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 88. IVPM Corporate Summary
Table 89. IVPM Anthrax Vaccines Product Offerings
Table 90. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 91. Prondil Corporate Summary
Table 92. Prondil Anthrax Vaccines Product Offerings
Table 93. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 94. CDV Corporate Summary
Table 95. CDV Anthrax Vaccines Product Offerings
Table 96. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 97. Indian Immunologicals Corporate Summary
Table 98. Indian Immunologicals Anthrax Vaccines Product Offerings
Table 99. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 100. Botswana Vaccine Institute Corporate Summary
Table 101. Botswana Vaccine Institute Anthrax Vaccines Product Offerings
Table 102. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 103. Ceva Santé Animale Corporate Summary
Table 104. Ceva Santé Animale Anthrax Vaccines Product Offerings
Table 105. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 106. Intervac Corporate Summary
Table 107. Intervac Anthrax Vaccines Product Offerings
Table 108. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 109. JOVAC Corporate Summary
Table 110. JOVAC Anthrax Vaccines Product Offerings
Table 111. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 112. Anthrax Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 113. Global Anthrax Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global Anthrax Vaccines Production by Region, 2017-2022 (M Doses)
Table 115. Global Anthrax Vaccines Production by Region, 2023-2028 (M Doses)
Table 116. Anthrax Vaccines Market Opportunities & Trends in Global Market
Table 117. Anthrax Vaccines Market Drivers in Global Market
Table 118. Anthrax Vaccines Market Restraints in Global Market
Table 119. Anthrax Vaccines Raw Materials
Table 120. Anthrax Vaccines Raw Materials Suppliers in Global Market
Table 121. Typical Anthrax Vaccines Downstream
Table 122. Anthrax Vaccines Downstream Clients in Global Market
Table 123. Anthrax Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anthrax Vaccines Segment by Type
Figure 2. Anthrax Vaccines Segment by Application
Figure 3. Global Anthrax Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anthrax Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anthrax Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Anthrax Vaccines Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Anthrax Vaccines Revenue in 2021
Figure 9. By Type - Global Anthrax Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anthrax Vaccines Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Anthrax Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anthrax Vaccines Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Anthrax Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anthrax Vaccines Sales Market Share, 2017-2028
Figure 19. US Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anthrax Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anthrax Vaccines Sales Market Share, 2017-2028
Figure 33. China Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anthrax Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anthrax Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anthrax Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anthrax Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anthrax Vaccines Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Anthrax Vaccines by Region, 2020 VS 2027
Figure 50. Anthrax Vaccines Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs